Us Pharmaceuticals
- All
- News
- Videos
-
"Trump's Win Beneficial For India's Export Trade": Economist Suriya Narayanan
India has an opportunity to export more goods to the US, including agro and pharmaceutical goods, said Indian Economist Suriya Narayan.
-
Trump's 'America First' Agenda May Lead To Tighter H-1B Visa Rules: Experts
With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the America First' agenda, opined trade experts.
-
Indian National Charged With Selling Counterfeit Pharmaceuticals In US
A US court on Thursday charged Sanjay Kumar from Bihar with selling and shipping tens of thousands of dollars' worth of counterfeit oncology pharmaceuticals into the country.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
"No Proof Against Us": Cough Syrup Firm Founder On Gambia Child Deaths
Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Big Oil Sued In US Over Climate Damages
Attorney Jeffrey B. Simon helped families affected by the opioid crisis obtain settlements worth more than $2.7 billion against leading pharmaceutical companies.
-
Cipla Recalls 6 Batches Of Bronchospasm Treatment Inhalation Aerosol In US
Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect.
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Indian-Origin Data Analyst Hit By Bus While Waiting At US Airport, Dies
Vishwachand Kolla, originally from Andhra Pradesh, was an employee of Takeda Pharmaceutical Company. He was at the Logan International Airport, Boston to pick up a visiting musician from the airport travelling to Boston.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
-
"Trump's Win Beneficial For India's Export Trade": Economist Suriya Narayanan
India has an opportunity to export more goods to the US, including agro and pharmaceutical goods, said Indian Economist Suriya Narayan.
-
Trump's 'America First' Agenda May Lead To Tighter H-1B Visa Rules: Experts
With Donald Trump all set to become US president, Indian exporters may face high customs duties for goods like automobiles, textiles and pharmaceuticals if the new US administration decides to pursue the America First' agenda, opined trade experts.
-
Indian National Charged With Selling Counterfeit Pharmaceuticals In US
A US court on Thursday charged Sanjay Kumar from Bihar with selling and shipping tens of thousands of dollars' worth of counterfeit oncology pharmaceuticals into the country.
-
Johnson & Johnson To Pay $700 Million In Talc Safety Settlement
US pharmaceutical and cosmetics giant Johnson & Johnson has agreed to pay $700 million to settle allegations it misled customers about the safety of its talcum-based powder products, New York's attorney general announced Tuesday.
-
What Is TTS, A Rare Condition Caused By AstraZeneca's Covishield Vaccine
AstraZeneca, a British pharmaceutical giant, has admitted that its Covid-19 vaccine can result ina rare side effectknown as Thrombosis with Thrombocytopenia Syndrome (TTS).T
-
US Approves First Drug For People With Severe Form Of Fatty Liver Disease
The US Food and Drug Administration (FDA) on Thursday approved the first medication for people with a severe type of non-alcoholic fatty liver disease.
-
"No Proof Against Us": Cough Syrup Firm Founder On Gambia Child Deaths
Maiden Pharmaceuticals, whose cough syrups have been linked to the deaths of children in Gambia, on Saturday denied it had tampered with test samples or
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Big Oil Sued In US Over Climate Damages
Attorney Jeffrey B. Simon helped families affected by the opioid crisis obtain settlements worth more than $2.7 billion against leading pharmaceutical companies.
-
Cipla Recalls 6 Batches Of Bronchospasm Treatment Inhalation Aerosol In US
Pharmaceutical firm Cipla Ltd on Friday said it is voluntarily recalling six batches of Albuterol Sulfate inhalation aerosol in the US market due to container defect.
-
Johnson & Johnson Proposes $9 Billion To Settle Cancer Claims: 5 Facts
Pharmaceutical giant Johnson & Johnson will pay $8.9 billion to settle thousands of lawsuits alleging that the talcum in its iconic baby powder caused cancer. However, the US company's proposal will need the approval of a bankruptcy court.
-
Johnson & Johnson's $9 Billion Offer To Settle 'Talc Caused Cancer' Claims
US pharmaceutical giant Johnson & Johnson on Tuesday proposed an $8.9 billion settlement to resolve years-old lawsuits claiming that its talcum powder products caused cancer.
-
Indian-Origin Data Analyst Hit By Bus While Waiting At US Airport, Dies
Vishwachand Kolla, originally from Andhra Pradesh, was an employee of Takeda Pharmaceutical Company. He was at the Logan International Airport, Boston to pick up a visiting musician from the airport travelling to Boston.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Johnson & Johnson Loses Key Tuberculosis Drug Patent In India
The Indian Patent Office on Thursday rejected US pharmaceutical giant Johnson and Johnson's application to extend its patent on a key tuberculosis treatment, allowing local companies to make cheaper generic versions.
